First Time Loading...

Allscripts Healthcare Solutions Inc
NASDAQ:MDRX

Watchlist Manager
Allscripts Healthcare Solutions Inc Logo
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Watchlist
Price: 7.99 USD 0.13% Market Closed
Updated: May 1, 2024

Allscripts Healthcare Solutions Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allscripts Healthcare Solutions Inc
Cash from Financing Activities Peer Comparison

Comparables:
VEEV
INSP
EVH
DOCS
GDRX

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Allscripts Healthcare Solutions Inc
NASDAQ:MDRX
Cash from Financing Activities
-$521m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
-14%
Veeva Systems Inc
NYSE:VEEV
Cash from Financing Activities
-$16.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Inspire Medical Systems Inc
NYSE:INSP
Cash from Financing Activities
$14m
CAGR 3-Years
-53%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Evolent Health Inc
NYSE:EVH
Cash from Financing Activities
$281.3m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Cash from Financing Activities
-$74.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Goodrx Holdings Inc
NASDAQ:GDRX
Cash from Financing Activities
-$167.4m
CAGR 3-Years
N/A
CAGR 5-Years
-47%
CAGR 10-Years
N/A

See Also

What is Allscripts Healthcare Solutions Inc's Cash from Financing Activities?
Cash from Financing Activities
-521m USD

Based on the financial report for Sep 30, 2022, Allscripts Healthcare Solutions Inc's Cash from Financing Activities amounts to -521m USD.

What is Allscripts Healthcare Solutions Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-14%

Over the last year, the Cash from Financing Activities growth was 60%. The average annual Cash from Financing Activities growth rates for Allscripts Healthcare Solutions Inc have been -14% over the past three years , and -14% over the past ten years .